Human Milk Oligosaccharides (HMO) Market - Size, Share, Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (2’FL, 3’FL, 3’SL, 6’SL); By Distribution Channel (Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, Online Sales Channel, Others); By Application (Infant Formula, Functional Food & Beverages, Food Supplements, Health Ingredients, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Global Human Milk Oligosaccharides (HMO) Market Size Booming More Than 4X at Robust CAGR of 23% During 2023–2029
Global Human Milk Oligosaccharides (HMO) market is gaining traction because of the growing awareness about the benefits of HMOs in infant nutrition, including supporting digestive health and technology advancements, such as microbial fermentation, enzymatic synthesis, and chemical synthesis, in HMO production.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global Human Milk Oligosaccharides (HMO) market size at USD 199 million in 2022. During the forecast period between 2023 and 2029, the global Human Milk Oligosaccharides (HMO) market size is projected to grow at a robust CAGR of 22.9% reaching a value of USD 842.78 million by 2029. The development of R&D efforts and the increasing usage of HMO as a component in infant formula are two major growth factors for the global market for HMO. One of the primary factors propelling the growth of the human milk oligosaccharides (HMO) market is the accessibility of cutting-edge technologies like enzymatic trans-glycosylation, which is used to artificially synthesis the HMOs.
Global Human Milk Oligosaccharides (HMO) Market – Overview
Human milk oligosaccharides (HMOs) are a group of complex carbohydrates and the third most prevalent solid substance in human milk after lipids and lactose. Mother's milk contains HMOs that are essential for the immune system and intestinal barrier development in a newborn. Some HMOs may also have an impact on how the infant's brain develops. Although there are more than 100 distinct kinds of HMOs, most moms' breast milk contains the most 2'-FL HMO (2'-fucosyllactose), which is the most common form.
Global Human Milk Oligosaccharides (HMO) Market – By Application
Based on application, the global Human Milk Oligosaccharides (HMO) market is segmented into infant formula, functional food & beverages, food supplements, health ingredients, and others. The infant formula segment accounts for the highest market share. These HMO supplements shield newborns against infection. Additionally, it helps gut health maintenance, protects them from prebiotic effects, and boosts cognition. Therefore, most infant formula-making food companies add this component into their products, due to which its demand is gaining traction in the market.
Impact of COVID-19 on Global Human Milk Oligosaccharides (HMO) Market
The market for Human Milk Oligosaccharides (HMO) was significantly impacted by the COVID-19 pandemic. Due to panic buying for at-home consumption during the early stages of the pandemic, the demand for HMOs soared during the lockdown. Because HMOs operate as an immunity booster, their sales increased during the pandemic as a result. However, restrictions on production activities and a shortage of labor also created a huge demand and supply gap that impacted the market revenue negatively in the later period of the COVID-19 outbreak. But it is estimated that the market will overall gain new opportunities owing to the rising health consciousness among consumers.
Competitive Landscape
Major players operating in the global Human Milk Oligosaccharides (HMO) market include Abbott Laboratories, FrieslandCampina Domo, DuPont Nutrition & Health, Jennewein Biotechnologie GmbH, Glycom A/S, Nestle S.A., Inbiose NV, ZuChem Inc., InnoBio Ltd., Elicityl SA, TCI Chemicals (India) Pvt. Ltd., Medolac Laboratories, Glycosyn LLC, Glycosyn-Stanford JV LLC, and ProZomix Limited.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Human Milk Oligosaccharides (HMO) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Human Milk Oligosaccharides (HMO) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
- 1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
- 2. Executive Summary
- 3. Global Human Milk Oligosaccharides (HMO) Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Growing awareness about the benefits of HMOs in infant nutrition, including supporting digestive health
- 3.2.1.2. Technological advancements in HMO production, such as microbial fermentation, enzymatic synthesis, and chemical synthesis
- 3.2.1.3. Rising prevalence of infant health issues, such as diarrhea, constipation, and allergies
- 3.2.2. Restraints
- 3.2.2.1. Stringent regulatory frameworks and labeling requirements for Human Milk Oligosaccharides (HMO)
- 3.2.2.2. Limited availability of HMOs from natural sources, as they are only found in human milk and can be difficult to extract and purify
- 3.2.3. Opportunities
- 3.2.3.1. Rising demand for natural and sustainable ingredients in food and beverage products
- 3.2.3.2. Expansion of the global infant formula market, particularly in emerging markets
- 3.2.4. Challenges
- 3.2.4.1. Increasing competition from alternative sources of functional ingredients, such as probiotics, prebiotics, and vitamins
- 3.3. Product Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter’s Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
- 4. Global Human Milk Oligosaccharides (HMO) Market Overview
- 4.1. Market Size & Forecast, 2019–2029
- 4.1.1. By Value (USD Million)
- 4.2. Market Share and Forecast
- 4.2.1. By Type
- 4.2.1.1. 2’FL
- 4.2.1.2. 3’FL
- 4.2.1.3. 3’SL
- 4.2.1.4. 6’SL
- 4.2.2. By Distribution Channel
- 4.2.2.1. Hypermarkets & Supermarkets
- 4.2.2.2. Drug Store or Pharmacy
- 4.2.2.3. Mass Merchandiser
- 4.2.2.4. Departmental Stores
- 4.2.2.5. Mono-brand Stores
- 4.2.2.6. Specialty Stores
- 4.2.2.7. Online Sales Channel
- 4.2.2.8. Others
- 4.2.3. By Application
- 4.2.3.1. Infant Formula
- 4.2.3.2. Functional Food & Beverages
- 4.2.3.3. Food Supplements
- 4.2.3.4. Health Ingredients
- 4.2.3.5. Others
- 4.2.4. By Region
- 4.2.4.1. North America
- 4.2.4.2. Europe
- 4.2.4.3. Asia Pacific (APAC)
- 4.2.4.4. Latin America (LATAM)
- 4.2.4.5. Middle East and Africa (MEA)
- 5. North America Human Milk Oligosaccharides (HMO) Market
- 5.1. Market Size & Forecast, 2019–2029
- 5.1.1. By Value (USD Million)
- 5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By Distribution Channel
- 5.2.3. By Application
- 5.2.4. By Country
- 5.2.4.1. United States
- 5.2.4.1.1. By Type
- 5.2.4.1.2. By Distribution Channel
- 5.2.4.1.3. By Application
- 5.2.4.2. Canada
- 5.2.4.2.1. By Type
- 5.2.4.2.2. By Distribution Channel
- 5.2.4.2.3. By Application
- 6. Europe Human Milk Oligosaccharides (HMO) Market
- 6.1. Market Size & Forecast, 2019–2029
- 6.1.1. By Value (USD Million)
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Distribution Channel
- 6.2.3. By Application
- 6.2.4. By Country
- 6.2.4.1. Germany
- 6.2.4.1.1. By Type
- 6.2.4.1.2. By Distribution Channel
- 6.2.4.1.3. By Application
- 6.2.4.2. United Kingdom
- 6.2.4.2.1. By Type
- 6.2.4.2.2. By Distribution Channel
- 6.2.4.2.3. By Application
- 6.2.4.3. Italy
- 6.2.4.3.1. By Type
- 6.2.4.3.2. By Distribution Channel
- 6.2.4.3.3. By Application
- 6.2.4.4. France
- 6.2.4.4.1. By Type
- 6.2.4.4.2. By Distribution Channel
- 6.2.4.4.3. By Application
- 6.2.4.5. Spain
- 6.2.4.5.1. By Type
- 6.2.4.5.2. By Distribution Channel
- 6.2.4.5.3. By Application
- 6.2.4.6. Belgium
- 6.2.4.6.1. By Type
- 6.2.4.6.2. By Distribution Channel
- 6.2.4.6.3. By Application
- 6.2.4.7. Russia
- 6.2.4.7.1. By Type
- 6.2.4.7.2. By Distribution Channel
- 6.2.4.7.3. By Application
- 6.2.4.8. The Netherlands
- 6.2.4.8.1. By Type
- 6.2.4.8.2. By Distribution Channel
- 6.2.4.8.3. By Application
- 6.2.4.9. Rest of Europe
- 6.2.4.9.1. By Type
- 6.2.4.9.2. By Distribution Channel
- 6.2.4.9.3. By Application
- 7. Asia Pacific Human Milk Oligosaccharides (HMO) Market
- 7.1. Market Size & Forecast, 2019–2029
- 7.1.1. By Value (USD Million)
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Distribution Channel
- 7.2.3. By Application
- 7.2.4. By Country
- 7.2.4.1. China
- 7.2.4.1.1. By Type
- 7.2.4.1.2. By Distribution Channel
- 7.2.4.1.3. By Application
- 7.2.4.2. India
- 7.2.4.2.1. By Type
- 7.2.4.2.2. By Distribution Channel
- 7.2.4.2.3. By Application
- 7.2.4.3. Japan
- 7.2.4.3.1. By Type
- 7.2.4.3.2. By Distribution Channel
- 7.2.4.3.3. By Application
- 7.2.4.4. South Korea
- 7.2.4.4.1. By Type
- 7.2.4.4.2. By Distribution Channel
- 7.2.4.4.3. By Application
- 7.2.4.5. Australia & New Zealand
- 7.2.4.5.1. By Type
- 7.2.4.5.2. By Distribution Channel
- 7.2.4.5.3. By Application
- 7.2.4.6. Indonesia
- 7.2.4.6.1. By Type
- 7.2.4.6.2. By Distribution Channel
- 7.2.4.6.3. By Application
- 7.2.4.7. Malaysia
- 7.2.4.7.1. By Type
- 7.2.4.7.2. By Distribution Channel
- 7.2.4.7.3. By Application
- 7.2.4.8. Singapore
- 7.2.4.8.1. By Type
- 7.2.4.8.2. By Distribution Channel
- 7.2.4.8.3. By Application
- 7.2.4.9. Vietnam
- 7.2.4.9.1. By Type
- 7.2.4.9.2. By Distribution Channel
- 7.2.4.9.3. By Application
- 7.2.4.10. Rest of APAC
- 7.2.4.10.1. By Type
- 7.2.4.10.2. By Distribution Channel
- 7.2.4.10.3. By Application
- 8. Latin America Human Milk Oligosaccharides (HMO) Market
- 8.1. Market Size & Forecast, 2019–2029
- 8.1.1. By Value (USD Million)
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Distribution Channel
- 8.2.3. By Application
- 8.2.4. By Country
- 8.2.4.1. Brazil
- 8.2.4.1.1. By Type
- 8.2.4.1.2. By Distribution Channel
- 8.2.4.1.3. By Application
- 8.2.4.2. Mexico
- 8.2.4.2.1. By Type
- 8.2.4.2.2. By Distribution Channel
- 8.2.4.2.3. By Application
- 8.2.4.3. Argentina
- 8.2.4.3.1. By Type
- 8.2.4.3.2. By Distribution Channel
- 8.2.4.3.3. By Application
- 8.2.4.4. Peru
- 8.2.4.4.1. By Type
- 8.2.4.4.2. By Distribution Channel
- 8.2.4.4.3. By Application
- 8.2.4.5. Rest of LATAM
- 8.2.4.5.1. By Type
- 8.2.4.5.2. By Distribution Channel
- 8.2.4.5.3. By Application
- 9. Middle East & Africa Human Milk Oligosaccharides (HMO) Market
- 9.1. Market Size & Forecast, 2019–2029
- 9.1.1. By Value (USD Million)
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Distribution Channel
- 9.2.3. By Application
- 9.2.4. By Country
- 9.2.4.1. Saudi Arabia
- 9.2.4.1.1. By Type
- 9.2.4.1.2. By Distribution Channel
- 9.2.4.1.3. By Application
- 9.2.4.2. UAE
- 9.2.4.2.1. By Type
- 9.2.4.2.2. By Distribution Channel
- 9.2.4.2.3. By Application
- 9.2.4.3. Qatar
- 9.2.4.3.1. By Type
- 9.2.4.3.2. By Distribution Channel
- 9.2.4.3.3. By Application
- 9.2.4.4. Kuwait
- 9.2.4.4.1. By Type
- 9.2.4.4.2. By Distribution Channel
- 9.2.4.4.3. By Application
- 9.2.4.5. South Africa
- 9.2.4.5.1. By Type
- 9.2.4.5.2. By Distribution Channel
- 9.2.4.5.3. By Application
- 9.2.4.6. Nigeria
- 9.2.4.6.1. By Type
- 9.2.4.6.2. By Distribution Channel
- 9.2.4.6.3. By Application
- 9.2.4.7. Algeria
- 9.2.4.7.1. By Type
- 9.2.4.7.2. By Distribution Channel
- 9.2.4.7.3. By Application
- 9.2.4.8. Rest of MEA
- 9.2.4.8.1. By Type
- 9.2.4.8.2. By Distribution Channel
- 9.2.4.8.3. By Application
- 10. Competitive Landscape
- 10.1. List of Key Players and Their Offerings
- 10.2. Global Human Milk Oligosaccharides (HMO) Market Share Analysis, 2022
- 10.3. Competitive Benchmarking, By Operating Parameters
- 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- 11. Impact of Covid-19 on Global Human Milk Oligosaccharides (HMO) Market
- 12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
- 12.1. Abbott Laboratories
- 12.2. FrieslandCampina Domo
- 12.3. DuPont Nutrition & Health
- 12.4. Jennewein Biotechnologie GmbH
- 12.5. Glycom A/S
- 12.6. Nestle S.A.
- 12.7. Inbiose NV
- 12.8. ZuChem Inc.
- 12.9. InnoBio Ltd.
- 12.10. Elicityl SA
- 12.11. TCI Chemicals (India) Pvt. Ltd.
- 12.12. Medolac Laboratories
- 12.13. Glycosyn LLC
- 12.14. Glycosyn-Stanford JV LLC
- 12.15. ProZomix Limited
- 12.16. Other Prominent Players
- 13. Key Strategic Recommendations
- 14. Research Methodology
- 14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
- 14.2. Quantitative Research
- 14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
- 14.4. Breakdown of Primary Research Respondents, By Region
- 14.5. Assumptions & Limitations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook